Editorial: Risks and Benefits of Adjuvants to Cancer Therapies

Por Peixin Dong, David A. Gewirtz, David A. Gewirtz
Publicado em 2022-05-01

Clearance of therapy‐induced senescent tumor cells by the senolytic ABT‐263 via interference with BCL‐XL–BAX interaction

Por Tareq Saleh, Valerie J. Carpenter, Liliya Tyutyunyk‐Massey, Graeme Murray, Joel D. Leverson, Andrew J. Souers, Moureq R. Alotaibi, Anthony C. Faber, Jason Reed, Hisashi Harada, David A. Gewirtz
Publicado em 2020-10-01